Benazepril HCl - CAS 86541-74-4
Catalog number:
86541-74-4
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C24H28N2O5·HCl
Molecular Weight:
460.95
COA:
Inquire
Targets:
Others
Description:
Benazepril is a drug of the angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
MSDS:
Inquire
1.A randomized, double-blind trial comparing the effects of amlodipine besylate/benazepril HCl vs amlodipine on endothelial function and blood
Mohler ER 3rd1, Herrington D, Ouyang P, Mangano C, Ritter S, Davis P, Purkayastha D, Gatlin M, Vogel RA; EXPLORE Investigators. J Clin Hypertens (Greenwich). 2006 Oct;8(10):692-8.
Evidence suggests that renin-angiotensin-aldosterone system inhibition ameliorates endothelial dysfunction. The authors examined the effect of amlodipine besylate/benazepril HCl combination treatment compared with amlodipine besylate monotherapy in modulating endothelial dysfunction. This multicenter, double-blind, 12-week study randomized 70 hypertensive subjects with at least one other endothelial dysfunction risk factor to amlodipine besylate/benazepril HCl (5/20 mg/d force-titrated to 5/40 mg/d) or amlodipine besylate monotherapy (5 mg/d force-titrated to 10 mg/d). Both the combination and monotherapy produced significant median increases from baseline in percentage flow-mediated vasodilation (2.0% and 1.2%, respectively) and percentage change in percent flow-mediated vasodilation (25% and 16%, respectively). These improvements were numerically larger with combination treatment, but between-group differences did not achieve statistical significance.
2.Formal synthesis of the ACE inhibitor benazepril x HCl via an asymmetric aza-Michael reaction.
Yu LT1, Huang JL, Chang CY, Yang TK. Molecules. 2006 Aug 23;11(8):641-8.
A formal enantioselective synthesis of benazepril.HCl (4), an anti- hypertensive drug, is reported. Our synthesis employed an asymmetric aza-Michael addition of L-homophenylalanine ethyl ester (LHPE, 1) to 4-(2-nitrophenyl)-4-oxo- but-2-enoic acid methyl ester (6) as the key step to prepare (2S,3'S)-2-(2-oxo-2,3,4,5- tetrahydro-1H-benzo[b]azepin-3-ylamino)-4-phenylbutyric acid ethyl ester (8), which is the key intermediate leading to benazepril x HCl (4).
3.Comparative study between univariate spectrophotometry and multivariate calibration as analytical tools for quantitation of Benazepril alone and in combination with Amlodipine.
Farouk M1, Elaziz OA1, Tawakkol SM2, Hemdan A3, Shehata MA4. Spectrochim Acta A Mol Biomol Spectrosc. 2014 Apr 5;123:473-81. doi: 10.1016/j.saa.2013.12.094. Epub 2014 Jan 3.
Four simple, accurate, reproducible, and selective methods have been developed and subsequently validated for the determination of Benazepril (BENZ) alone and in combination with Amlodipine (AML) in pharmaceutical dosage form. The first method is pH induced difference spectrophotometry, where BENZ can be measured in presence of AML as it showed maximum absorption at 237nm and 241nm in 0.1N HCl and 0.1N NaOH, respectively, while AML has no wavelength shift in both solvents. The second method is the new Extended Ratio Subtraction Method (EXRSM) coupled to Ratio Subtraction Method (RSM) for determination of both drugs in commercial dosage form. The third and fourth methods are multivariate calibration which include Principal Component Regression (PCR) and Partial Least Squares (PLSs). A detailed validation of the methods was performed following the ICH guidelines and the standard curves were found to be linear in the range of 2-30μg/mL for BENZ in difference and extended ratio subtraction spectrophotometric method, and 5-30 for AML in EXRSM method, with well accepted mean correlation coefficient for each analyte.
4.Efficacy of combination therapy for systolic blood pressure in patients with severe systolic hypertension: the Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) study.
Neutel JM1, Smith DH, Weber MA, Schofield L, Purkayastha D, Gatlin M. J Clin Hypertens (Greenwich). 2005 Nov;7(11):641-6; quiz 647-8.
Systolic hypertension is predominant among patients over 50 years of age, is a more important cardiovascular risk factor than diastolic blood pressure, and is more difficult to control than diastolic blood pressure. Consequently, the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) recommends combination therapy as first-line treatment for patients with stage 2 hypertension. In the Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) study, 24-hour ambulatory blood pressure monitoring was used to identify patients with systolic hypertension and to determine the impact of 8 weeks of treatment with either amlodipine besylate/benazepril HCl 5/20 mg combination therapy (n=149), amlodipine besylate 5 mg (n=146), or benazepril HCl 20 mg (n=148). Combination therapy was significantly more effective in reducing systolic blood pressure and pulse pressure than either monotherapy (p<0.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 135202-79-8 Ilonidap

Ilonidap
(CAS: 135202-79-8)

Ilonidap is an anti-Inflammatory agent. No detailed information has been published yet.

CAS 1345808-25-4 Arginase inhibitor 1

Arginase inhibitor 1
(CAS: 1345808-25-4)

Arginase inhibitor 1 is active in a recombinant cellular assay overexpressing humanarginase I (CHO cells). It is 28% orally bioavailable and significantly reduc...

CAS 4884-68-8 Hydrastinine hydrochloride

Hydrastinine hydrochloride
(CAS: 4884-68-8)

Hydrastinine hydrochloride is a semisynthetic alkaloid as a haemostatic drug.

CAS 1195-16-0 DL-N-Acetylhomocysteine thiolactone

DL-N-Acetylhomocysteine thiolactone
(CAS: 1195-16-0)

DL-N-Acetylhomocysteine thiolactone, an amino acid cysteine derivative, could be used against some liver diseases.

CAS 328232-95-7 MK 0557

MK 0557
(CAS: 328232-95-7)

MK-0557 is a highly selective, orally administered neuropeptide NPY5R antagonist, could limit weight regain after very-low-calorie diet (VLCD)-induced weight lo...

CAS 83-12-5 Phenindione

Phenindione
(CAS: 83-12-5)

Phenindione is an anticoagulant which functions as a Vitamin K antagonist.

CAS 2207-75-2 Oxonic acid potassium salt

Oxonic acid potassium salt
(CAS: 2207-75-2)

Oxonic acid potassium salt is an inhibitor of uricase. It has been used for the inhibition of 5-fluorouracil-induced gastrointestinal toxicity without the loss ...

BPH-652
(CAS: 157124-84-0)

BPH-652, also known as BMS-187745, has been found to be a SQS inhibitor that could probably be effective against S. aureus infections.

CAS 117-10-2 1,8-Dihydroxyanthraquinone

1,8-Dihydroxyanthraquinone
(CAS: 117-10-2)

1,8-Dihydroxyanthraquinone, an anthraquinone derivative, could be widely used as antioxidant, dye intermediate and a raw material to synthesise sorts of product...

CAS 55981-09-4 Nitazoxanide

Nitazoxanide
(CAS: 55981-09-4)

Nitazoxanide is a synthetic nitrothiazolyl-salicylamide derivative and an antiprotozoal agent. (IC50 for canine influenza virus ranges from 0.17 to 0.21 μM)

MK 0927
(CAS: 126453-94-9)

MK 0927 is a potential bio-active agent., but no detail information has been published yet.

CAS 84687-42-3 Astragaloside III

Astragaloside III
(CAS: 84687-42-3)

Astragaloside III is a saponin found in the root of Astragalus membranaceus (Fisch.) Bunge, which is known as huáng qí in Traditional Chinese Medicine. It has c...

CW 008
(CAS: 1134613-19-6)

This active molecular is a cAMP/PKA/CREB pathway activator promoting osteogenic differentiation of human bone marrow derived MSCs in vitro, and it also increase...

CAS 1216744-19-2 GSK4112

GSK4112
(CAS: 1216744-19-2)

GSK 4112, a kind of synthetic agonist of REV-ERBα, could suppress the expression of sorts of genes involved in gluconeogenesis. IC50: 0.4 μM (EC50).

CB 3731
(CAS: 80015-07-2)

CB 3731 can be used in fluorine-19 nuclear magnetic resonance studies of binary and ternary complexes of thymidylate synthase.

CAS 23674-86-4 Difluprednate

Difluprednate
(CAS: 23674-86-4)

Difluprednate (difluoroprednisolone butyrate acetate, or DFBA) is a synthetic difluorinated prednisolone derivative, it is originally developed for dermatologic...

CAS 736994-63-1 Cyantraniliprole

Cyantraniliprole
(CAS: 736994-63-1)

Cyantraniliprole is an insecticide of the ryanoid class. It has activity against pests such as Diaphorina citri.

CAS 144494-65-5 Tirofiban HCl

Tirofiban HCl
(CAS: 144494-65-5)

Tirofiban (MK-383, Aggrastat) is a nonpeptide derivative of tyrosine that selectively inhibits the GP-IIb/IIIa receptor, with minimal effects on the ɑvβ3 vitron...

ARV-825
(CAS: 1818885-28-7)

ARV-825, a BRD4 inhibitor, has extensive anti-AML activity and modulates tumor microenvironment and metabolism to overcome stromamediated drug resistance. DC50...

CAS 162784-72-7 7-Epi-10-oxo-docetaxel

7-Epi-10-oxo-docetaxel
(CAS: 162784-72-7)

Docetaxel Impurity

Chemical Structure

CAS 86541-74-4 Benazepril HCl

Quick Inquiry

Verification code

Featured Items